Abteilung für Krebsforschung (DOCR)

Unsere Vision ist es, das Leben der Patienten zu verbessern, indem wir den Kampf gegen Krebs vorantreiben. Auf der Grundlage solider wissenschaftlicher Ergebnisse konzentrieren wir uns auf vorrangige Forschungsbereiche und bieten Forschungsexpertise zu den häufigsten und/oder bösartigsten Krebsarten, die in Luxemburg eine Gesundheitsbelastung darstellen. Die Abteilung stellt auch eine hochmoderne Ausbildungsstätte für die nächste Generation von Krebsforschern dar und fungiert als Referenzpunkt für die Krebsforschung in Luxemburg. 

Aufgaben

Die Hauptaufgabe des Department of Cancer Research besteht darin, die Optionen für die Behandlung von Krebs zu erweitern und zu verbessern sowie die Krebslast in der luxemburgischen Bevölkerung und darüber hinaus zu verringern. Wir tun dies durch exzellente Forschung in Prioritätsbereichen, die von der Grundlagen- über die translationale bis zur klinischen Forschung reichen, um Programme für personalisierte Medizin zu fördern. Der Schwerpunkt unserer Aktivitäten liegt auf schwer zu behandelnden Krebsarten, und unsere Teams verfügen jeweils über Spezialkompetenzen in Krebsimmunologie, der Mikroumgebung von Tumoren, Tumorstoffwechsel und Neuroonkologie. Wir erforschen die zellulären und molekularen Mechanismen der Tumorprogression mithilfe einer breiten Palette modernster Technologien, u. a. multimodalen Omik-Technologien (Genomik, Metabolomik…), erweiterten Analysen zur Immunprofilierung sowie Ex-vivo- und In-vivo-Bildgebungsmodalitäten, für die wir Patientendaten und innovative patientenabgeleitete Modelle für die Krebsforschung nutzen. 

LEITUNG DES DEPARTMENT

Johannes
Meiser

Projekte und klinische Versuche

Krebs Wechselwirkungen von Tumorstroma
Extracellular vesicle RNA as systemic modulators of the tumor microenvironment in B cell lymphoma
Krebs Wechselwirkungen von Tumorstroma
Study of chronic lymphocytic exosomes and their impact on leukemogenesis
Krebs Wechselwirkungen von Tumorstroma
Role of AHR and HIF1α transcription factors in normal and chroniclymphocytic leukemia B lymphocytes
Krebs Wechselwirkungen von Tumorstroma
Inhibition of prohibitins and translation in chronic lymphocytic leukemi
Krebs Wechselwirkungen von Tumorstroma
Characterization of the tumor and its microenvironment in chronic lymphocytic leukemia
Krebs Wechselwirkungen von Tumorstroma
Role of regulatory T cells in the development and progression of chroniclymphocytic leukemia
Krebs Wechselwirkungen von Tumorstroma
Reprogramming of the leukemic microenvironment by small extracellular vesicles: from characterization totherapeutic application
Krebs Gruppe Krebs-Stoffwechsel
Involvement of leukemic-derived extracellular vesicles in tumor microenvironment metabolic rewiring
Krebs Wechselwirkungen von Tumorstroma
Impact of Chronic Lymphocytic Leukemia-derived extracellular vesicles onthe microenvironment immune landscape
Krebs Wechselwirkungen von Tumorstroma
Immunotherapies and drug screening in improved patient-derived models: a translational approach towards personalized treatments for leukaemia
Parkinson Neuro-Immunologie Gruppe
Microglia programs under PARK7/DJ-1 deficiency, a genetic cause of Parkinson’s disease
Krebs Gruppe Krebs-Stoffwechsel
Understanding the Flexibility of 1C metabolism and its role during metastatic dissemination of cancer cell
Krebs Immuno-Pharmakologie und Interaktomik
Targeting chemokine receptors for improved cancer immunotherapy
Immunologische Störungen  Neuro-Immunologie Gruppe
Systems analysis of astrocytes differentiation under inflammatory conditions
Krebs Neuro-Immunologie Gruppe
Prognostic Impact of Monocyte subsets in Patients with Glioblastoma
Krebs Neuro-Immunologie Gruppe
Shifting immune-suppressed monocyte-derived macrophage programs into microglia-like reactive cells in Glioblastoma
Krebs DNA-Reparatur und Chemoresistenz
Harnessing DNA repair factors to promote an innate immune response against glioblastoma: an invitro RNAi screen selecting phagocytosis promoting genes in glioblastoma cells
Krebs DNA-Reparatur und Chemoresistenz
Impact of MGMT on tumor development and resistance to temozolomide inglioblastoma: in vitro and in vivo characterization using novel GBM models
Krebs DNA-Reparatur und Chemoresistenz
A NOVEL PERSONALIZED STRATEGY TARGETING DNA REPAIR PATHWAY ADDICTIONS IN GLIOBLASTOMA: FROM PATIENT STRATIFICATION TO PRECLINICAL VALIDATION
Krebs DNA-Reparatur und Chemoresistenz
Roles of NEIL3 DNA glycosylase in telomere dynamics and DNA demethylation in glioblastoma: From molecular insights topreclinical target validation
Krebs
Training in Cancer Biology: Focus on Tumour Escape Mechanisms
Krebs Wechselwirkungen von Tumorstroma
Exosome proteins and RNA as biomarkers of prostate cancer progression and metastasis
Krebs DNA-Reparatur und Chemoresistenz
Targeting DNA repair mechanisms in primary glioblastoma and their recurrences: from basic mechanisms to pre-clinical aspects and personalized therapy
Krebs
Role of hypoxia in the establishment of an immune suppressive tumour microenvironment
Krebs Neuro-Immunologie Gruppe
Addressing the role of tumour associated microglia/macrophages in glioblastoma
Krebs Präzisionsmedizin
National Centre of Translational Cancer Research
Krebs
Improving cancer immunotherapy based on anti-PD-1 and STING agonists by combining small innovative molecule
Krebs
Personal Functional Profiling
Krebs
4th Lecture Series in Cancer Research
Krebs
3rd Lecture Series in Cancer Research
Krebs Immuno-Pharmakologie und Interaktomik
Targeting chemokine receptors: An innovative strategy to reprogram cold to hot tumor microenvironment and to improve PD-1-based cancer immunotherapy
Krebs
Impact of the immunomodulatory effect of the combination HDACis/IMiDs in myelome multiple (MM).
Krebs
CD47 and PD-1 blockade: a new cutting edge COMBI approach to simultaneously stimulate macrophages and re-activate T cell-mediated destruction of highly aggressive metastatic breast tumors
Krebs
Effect of PD-L1 blockade along with autophagy inhibition on the anti-tumor immune response
Krebs
Combining selective pharmacological inhibitors of autophagy with NK immune checkpoint blockade anti-KIR: An innovative approach to improve NK-based cancer immunotherapy
Krebs
Improving T-cell and Macrophage Immune checkpoint blockades by combining autophagy inhibitors
Krebs
EMT-dependent regulation of the ectonucleotidase CD73 in Triple Negative Breast Cancer and its role as a new therapeutic target
Krebs
Impact of the modulation of the intratumoral hypoxia on the improvement ofPD-1/PD-L1-based immune checkpoint blockade
Krebs
IMPROVING CANCER IMMUNOTHERAPY BY TARGETING HYPOXIA
Krebs
Combining JQI and PD-1 as an innovative approach for the treatment of Childhood Neuroblastoma.
Krebs
Effect of PD-1/PD-L1 immune checkpoint blockade on NK cell-mediated anti-tumor immune response
Krebs
Targeted delivery of theragnostic nanoparticles in glioblastoma
Krebs
Investigating the role of CMTM proteins in the regulation of PD-L1 expression
Krebs Immuno-Pharmakologie und Interaktomik
Role of chemokine receptor-bearing extracellular vesicles in leukaemia and lymphoma
Parkinson Krebs
In Vivo Imaging Platform
Parkinson Krebs
MRgFUS facilitated local treatment of brain tumors
Krebs
Assessment the impact of selective ALDH1 inhibitors on tumor infiltrating lymphocytes and the therapeutic benefit of Immune checkpoint blockers
Krebs
CHECKPOINT INHIBITORS IMPROVEMENT FOR THE TREATMENT OF CANCER
Krebs
Predictive biomarker profile for tumour and patient stratification for CyPep-1 guided ICI-therapy
Krebs Digitale Gesundheit
Predictive and personalized medicine of pancreatic cancer
Krebs Klinische Forschung
Personalized Functional Profiling – PFP
Klinische Studien Teilnehmen
Krebs Gruppe Krebs-Stoffwechsel
CANBIO2
Krebs DNA-Reparatur und Chemoresistenz
Targeting homologous recombination and replication stress in glioblastoma: from molecular insights to synthetic lethality approaches
Krebs Wechselwirkungen von Tumorstroma
DEVELOPMENT OF NEW TOOLS AND THERAPEUTICS FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Krebs Wechselwirkungen von Tumorstroma
CYTOTOXIC CD4+ T CELLS AS NOVEL IMMUNOTHERAPY IN CLL AND OTHER B-CELL MALIGNANCIES
Krebs Gruppe Krebs-Stoffwechsel
Role for the Itaconate/Nrf2 axis in metabolic and epigenetic reprogramming of neonatal macrophages
Krebs Gruppe Krebs-Stoffwechsel
Targeting ALDH1L2 to enforce ER-stress sensitivity of cancer
Krebs Multi-omics Data Science Forschung
IPerGlio: Improving personalized glioblastoma care by intertwined immunomics and artificial intelligence approaches
Krebs
Creation of National Comprehensive Cancer Centres and EU Networking
Krebs
PERSONAL FUNCTIONAL PROFILING FOR DRUG DISCOVERY IN MELANOMA AND COLORECTAL CANCER
Krebs
Establishing of national cancer mission hubs and creation of network to support the mission on cancer
Krebs Neuro-Immunologie Gruppe
Prognostic impact of circulating monocyte subsets in glioblastoma patients
Krebs Wechselwirkungen von Tumorstroma
Overcoming treatment resistance with new therapeutic opportunities in leukaemia
Immunologische Störungen  Präzisionsmedizin
Impact of the interplay between microglia, astrocytes and infiltrating immune cells in neuroinflammatory mechanisms in Alzheimer’s disease.
Krebs
Improving the Therapeutic benefit of immunotherapy in Neuroblastoma by combining autophagy inhibitor and anti-PD-i
Krebs Präzisionsmedizin
Deconvolution of complex molecular signals of metabolomics and transcriptomics for predicting drug sensitivity and therapy resistance in malignant melanoma
Covid-19 – Infektionskrankheiten Multi-omics Data Science Forschung
Dynamics modelling from single-cell data
Krebs
Investigating the mode of action of ACB1801 on increasing TAP1 and improving cancer immunotherapy
Krebs
A Coordination and Support Action to prepare UNCAN.eu platform
Krebs Gruppe Krebs-Stoffwechsel
Targeting Metastasis via its metabolic Achilles heel by exploiting BI-4916X and CompoundX
Krebs Wechselwirkungen von Tumorstroma
Translation as Novel Therapeutic Target in CLL
Krebs Neuro-Immunologie Gruppe
NR1D2 circadian clock gene as a target for reverting glioblastoma associated-immunosuppression via functional modulation of myeloid cells.
Krebs Wechselwirkungen von Tumorstroma
Role of the transcription factors AHR and HIF-1alpha in the suppressive ability of regulatory T cells in chronic lymphocytic leukemia
Krebs Gruppe Krebs-Stoffwechsel
Deciphering the role of the microbiome-derived oncometabolite formate on the immune cell compartment in colorectal cancer
Krebs DNA-Reparatur und Chemoresistenz
Impact of intratumoral heterogeneity on treatment resistance and tumor relapse in glioblastoma
Krebs Präzisionsmedizin
American Society of Hematology Global Research Award
Krebs Neuro-Immunologie Gruppe
Elucidating the role of the IRG1/ACOD1-itaconate axis in TAMs polarization in glioblastoma
Krebs
Role of hypoxia-induced autophagy in natural killer cell-mediated antitumor immune response
Krebs
Targeting Intra-Tumor hypoxia and PD-L1 (TLV-2016)
Krebs
Anti-glycation drugs as immunotherapy
Krebs
Improving the efficacy of renal cell carcinoma immunotherapy by combining anti-PD-1 and anti-CD47 immune checkpoints
Covid-19 – Infektionskrankheiten
Comparative antiviral efficacy of different autophagy inhibitors against COVID-19
Krebs
Identification of new common predictive biomarkers to stratify TNBC breast cancer patients for treatment with emerging immune checkpoints
Krebs DNA-Reparatur und Chemoresistenz
Harnessing DNA repair factors to promote an innate immune response against glioblastoma
Krebs Neuro-Immunologie Gruppe
Impact of the Adaptive Immunity on the Delayed Glioma Progression in a Mouse Model of Allergic Inflammation
Krebs Wechselwirkungen von Tumorstroma
Bioengineered small extracellular vesicles (sEV) as new cancer immunotherapies to counteract immune suppression
Krebs Wechselwirkungen von Tumorstroma
Immunometabolism adaptation in leukemia/lymphoma and new therapeutic opportunities
Krebs
Strengthening research capacities of comprehensive cancer infrastructures
Multi-omics Data Science Forschung
Consolidating the capacities of EATRIS-ERIC for Personalised Medicine
Krebs Wechselwirkungen von Tumorstroma
Translation as novel therapeutic target in leukemia/lymphoma
Krebs Multi-omics Data Science Forschung
Pre-operative methylation-based brain tumor classification
Krebs Gruppe Krebs-Stoffwechsel
Delineating the role of caclium signaling in controlling formate overflow
Multi-omics Data Science Forschung
Consolidating the capacities of EATRIS-ERIC for Personalised Medicine
Parkinson Krebs
Optimization of image acquisition protocols in Magnetic resonance Imaging (MRI) in oncology and neurology applications
Krebs
Strengthening research capacities of comprehensive cancer infrastructures
Krebs Translationale Radiomik
Jury member for Doctoral thesis of Stefania Chounta, University Paris-Saclay
Krebs
Exosomes in B-cell malignancies
Krebs
ACTIVASION project
Krebs
Improving cancer immunotherapy based on anti-PD-1 and STING agonists by combining small innovative molecules (SMART-COMBO)
Krebs
Elucidating tumour-associated microglia/macrophage heterogeneity for personalized immunotherapy in Glioblastoma
Krebs Präzisionsmedizin
Glioma Longitudinal AnalySiS in Luxembourg: ex vivo and in vivo Functional Profiling of Recurrent Gliomas
Krebs Gruppe Krebs-Stoffwechsel
The importance of being MitoFit: targeting mitochondrial metabolism in glioblastoma multiforme
Krebs Gruppe Krebs-Stoffwechsel
Identifying metabolic vulnerabilities in 3D
Krebs NORLUX-Labor für Neuro-Onkologie
Tumour plasticity as a treatment resistance mechanism in glioblastoma.
Krebs Proteomik der Zellulären Signalübertragung
Personalized Medicine Acceleration through Rapid Omics Profiling
Krebs Gruppe Krebs-Stoffwechsel
Formate-dependent Regulation of Cancer Metastasis
Krebs
6th Lecture Series in CANCER RESEARCH
Krebs
What is wrong with you, cancer cell?
Department of Medical Informatics
Minimal Viable Dataset
Krebs Gruppe Krebs-Stoffwechsel
Understanding and targeting the function of formate overflow in cancer cells
Krebs Zytoskelett und Krebsausbreitung
Novel synaptic filopodium-like protrusions (SFPs) protect tumor cells against cytotoxic lymphocyte-mediated killing
Immunologische Störungen  Neuro-Immunologie Gruppe
Elucidating the Molecular Heterogeneity of Microglia
Krebs DNA-Reparatur und Chemoresistenz
DNA repair mechanisms as molecular determinants of glioblastomachemoresistance: in vitro investigation and characterization of novel animalmodels
Krebs Präzisionsmedizin
TARGETING TUMOR PROPAGATING CELLS IN GLIOBLASTOMA: FROM MECHANISTICINSIGHTS TO PRECISION MEDICINE
Krebs NORLUX-Labor für Neuro-Onkologie
Targeting the glycolytic metabolism induced by anti-angiogenic treatment in Glioblastoma
Krebs NORLUX-Labor für Neuro-Onkologie
Development of methodologies for monitoring cancer progression and predicting treatment response
Krebs Multi-omics Data Science Forschung
Development of methodologies for monitoring cancer progression and predicting treatment response
Krebs NORLUX-Labor für Neuro-Onkologie
Novel therapeutic agents to target escape mechanisms from anti-angiogenic treatment in Glioblastoma
Krebs NORLUX-Labor für Neuro-Onkologie
Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics
Parkinson NORLUX-Labor für Neuro-Onkologie
NPath
Krebs NORLUX-Labor für Neuro-Onkologie
Innovative Models and Oncolytic Viruses for Immunotherapy of Glioblastoma
Krebs NORLUX-Labor für Neuro-Onkologie
ImmoGBM
Krebs NORLUX-Labor für Neuro-Onkologie
Targeting Glioma Cell Invasion
Krebs NORLUX-Labor für Neuro-Onkologie
Implication of LncRNAs in chemoresistance in Glioblastom
Krebs NORLUX-Labor für Neuro-Onkologie
LRIG1: an Endogenous Inhibitor for Pan-Receptor Tyrosine Kinase Targeting in Glioblastoma
Krebs NORLUX-Labor für Neuro-Onkologie
A multi-omics based single-cell strategy to overcome therapy-driven resistance in Glioblastoma: An entry-point for personalized treatment
Krebs NORLUX-Labor für Neuro-Onkologie
Targeted Epigenetic Therapy for Relapsed Glioblastoma
Krebs NORLUX-Labor für Neuro-Onkologie
Moving innovative oncolytic virus-based therapies into the clinic
Krebs NORLUX-Labor für Neuro-Onkologie
Development of novel oncolytic Paroviruses with ability to silence the TRAF3IP2 Gene as novel therapeutics against Glioblastoma
Krebs Proteomik der Zellulären Signalübertragung
MS-based proteomic approach to characterize phosphosignaling in glioblastoma
Krebs NORLUX-Labor für Neuro-Onkologie
Training of next generation of European glioblastoma (translational) researchers, to resolve precision targeting of the brain tumour microenvironment
Krebs NORLUX-Labor für Neuro-Onkologie
IMPACT OF EPITRANSCRIPTOMIC REGULATION ON RESPONSE TO PHARMACOLOGICAL TREATMENTS IN GLIOMAS
Krebs Translationale Radiomik
Pseudo PET imaging of brain tumor hypoxia
Krebs DNA-Reparatur und Chemoresistenz
Roles of the epigenetic reader MBD1 in IDH1-mutated gliomas
Krebs NORLUX-Labor für Neuro-Onkologie
Chemoresistance-related RNAs in GBM
Krebs NORLUX-Labor für Neuro-Onkologie
Impact of IDH1 mutation on Epitranscriptome regulation in Gliomas
Krebs NORLUX-Labor für Neuro-Onkologie
INVOLVEMENT OF LONG NON-CODING RNA MECHANISMS IN GLIOBLASTOMA
Krebs NORLUX-Labor für Neuro-Onkologie
In search of RNA Therapeutic Drugs in Oncology
Krebs NORLUX-Labor für Neuro-Onkologie
Reverting Cancer Driver Mutations in Gliomas
Krebs NORLUX-Labor für Neuro-Onkologie
TACKLING TUMOR HETEROGENEITY AND PLASTICITY AS RESISTANCE MECHANISMS IN GLIOBLASTOMA
Krebs Zytoskelett und Krebsausbreitung
Role of ICAM-1 in mediating actin remodeling-dependent tumor immune evasion
Krebs Präzisionsmedizin
Targeting tumor propagating cells in glioblastoma: from mechanistic insights to precision medicine
Immunologische Störungen  Gruppe Krebs-Stoffwechsel
Multi-dimensional resolution of tryptophan-driven immune-metabolism as a novel pathophysiologicalprinciple in inflammatory bowel disease
Krebs Immunologische Störungen 
The role of mitochondrial folate metabolism during macrophage polarization (Mac1L)
Krebs Immuno-Pharmakologie und Interaktomik
SMART GLIOBLASTOMA: Signaling and Modulation of the AtypicalIsoform of the CXCR3 RecepTor in glioblastoma cells
Krebs Multi-omics Data Science Forschung
Deconvolution of heterogeneity in the Glioblastoma cellular ecosystem for understanding treatment resistance and improving patient stratification
Krebs Zytoskelett und Krebsausbreitung
High-content drug screening to inhibit actin cytoskeleton-mediated cancer immune evasion
DNA-Reparatur und Chemoresistenz Multi-omics Data Science Forschung
TARGETING TUMOR PROPAGATING CELLS IN GLIOBLASTOMA: FROM MECHANISTICINSIGHTS TO PRECISION MEDICINE
Krebs Zytoskelett und Krebsausbreitung
Reciprocal effects of intrinsic tumour immune resistance and the tumour microenvironment
NORLUX-Labor für Neuro-Onkologie
Training of next generation of European glioblastoma (translational) researchers, to resolve precision targeting of the brain tumour microenvironment
Parkinson Gruppe Krebs-Stoffwechsel
Contribution of Astrocyte Metabolism to Synucleinopathy in Parkinson’s disease.
Krebs Zytoskelett und Krebsausbreitung
OVERCOMING TUMOR IMMUNE EVASION BY TARGETING THE ACTIN RESPONSE
Krebs Klinische Forschung
Glioma Longitudinal AnalySiS in Luxembourg (GLASS-LUX): ex vivo and in vivo Functional Profiling of Recurrent Gliomas
Krebs Proteomik der Zellulären Signalübertragung
Targeting a key promoter of multiple pro-metastatic pathways in breast cancer
Krebs Zytoskelett und Krebsausbreitung
Actin cytoskeleton remodeling in tumor immune evasion – mechanisticaspects
Krebs
5th Lecture Series in Cancer Research
Krebs Zytoskelett und Krebsausbreitung
CRP2, an innovative target for metastatic breast cancer, with multiple rolesin the tumour and tumour microenvironmen
Krebs Präzisionsmedizin
Precision medicine for Glioblastoma patients: a patient-based pre-clinical platform for immuno-oncology
Krebs Zytoskelett und Krebsausbreitung
The Student Training Project
Krebs Zytoskelett und Krebsausbreitung
Inhibition of breast cancer metastasis by targeting critical cytoskeletal components of invadopodia
Krebs Zytoskelett und Krebsausbreitung
Tumour microenvironment-induced invadopodia formation in cancer-associated fibroblasts: role in tumour cell invasion and metastasis
Krebs Zytoskelett und Krebsausbreitung
CRP2, an innovative target to inhibit invadopodia activity and pro-metastatic MMP expression in breast cancer
Krebs Zytoskelett und Krebsausbreitung
A LIM domain protein with multiple roles in breast cancer progression and metastas
Krebs Zytoskelett und Krebsausbreitung
Inhibition of Breast Cancer Metastasis by Co-targeting Two Actin Regulators
Alle Projekte auf unserem Forschungsportal anzeigen

Ausgewählte Teammitglieder

  • Rafael
    Barros     Laboratory Assistant
  • Elisabetta
    Bartolini     PhD Student
  • Michaela
    Bauer     Postdoctoral Fellow
  • Amandine
    Bernard     Laboratory Technician
  • Coralie
    Borne     Postdoctoral Fellow
  • Selma
    Boudissa     Research Engineer
  • Eleonora
    Campus     PhD Student
  • Maryna
    Chepeleva     PhD Student
Mehr laden
Alles anzeigen

Wissenschaftliche Veröffentlichungen

letzter
Mehr laden
Alles anzeigen

Ähnliche News

Alle News

CANBIO

CANBIO ist ein Forschungs- und Ausbildungsprogramm für Doktoranden, das sich mit dem immer wichtiger werdenden klinischen Problem des Fortschreitens (Progress) und Wiederkehrens (Rezidiv) von Tumoren befasst. In CANBIO aufgenommene Doktoranden werden in kooperativ und interdisziplinär konzipierten Projekten daran arbeiten, neue Einblicke in die Escape-Mechanismen von Tumoren, die Überwachung von Erkrankungen und groß angelegte Datenanalysen bei besonders aggressiven Krebsarten zu gewinnen. 

Mehr erfahren

i2TRON

TTM übernimmt eine führende Rolle bei der Koordinierung von i2TRON, einer doctoral training unit (DTU) mit besonderem Schwerpunkt auf der Ausbildung der nächsten Generation von Wissenschaftlern, die Beobachtungen im Labor, in einer klinischen Umgebung oder innerhalb einer Gemeinschaft in Interventionen überführen können, die die Gesundheit des einzelnen Patienten mit innovativer Diagnostik und Therapie verbessern.

Weitere Informationen finden Sie auf der entsprechenden Website:  

Mehr erfahren

Stellenanzeigen



View all jobs